|Bid||8.70 x 1300|
|Ask||8.93 x 1200|
|Day's Range||8.78 - 9.60|
|52 Week Range||7.86 - 30.99|
|Beta (5Y Monthly)||-1.93|
|PE Ratio (TTM)||5.84|
|Earnings Date||May 12, 2021 - May 17, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||23.00|
The CEO of Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, appeared yesterday on Yahoo! Finance to comment on the Company's recently-released FY2020 earnings report, and to discuss its going-forward strategy as the world struggles to achieve normalization.
Co-Diagnostics CEO Dwight Egan joined the Yahoo Finance Live panel to discuss the company's Q4 earnings results, along with the latest at-home COVID-19 testing outlook.
The analysts covering Co-Diagnostics, Inc. ( NASDAQ:CODX ) delivered a dose of negativity to shareholders today, by...